SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | n/a |
Enterprise Value ($M) | n/a |
Book Value ($M) | 54.03 |
Book Value / Share | 0.40 |
Price / Book | n/a |
NCAV ($M) | 6.12 |
NCAV / Share | 0.04 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.87 |
Return on Assets (ROA) | -0.78 |
Return on Equity (ROE) | -1.02 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.43 |
Current Ratio | 1.43 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 44.39 |
Assets | 65.66 |
Liabilities | 38.27 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 4.20 |
Operating Income | -116.50 |
Net Income | -113.90 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -104.50 |
Cash from Investing | -0.80 |
Cash from Financing | 0.60 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
CVSI – CV Sciences, Inc. | CYAN – Cyanotech Corporation |
CYDY – CytoDyn Inc. | DMKPQ – DMK Pharmaceuticals Corporation |
DRNK – NOHO, Inc. |
Financial data and stock pages provided by
Fintel.io